31 Mar 2023
Assets17.57
Total Income16.25
EBITDA1.70
Profit After Tax0.33
NET Worth2.44
Reserves and Surplus2.34
Total Borrowing9.61
At a glance
Updated 2026-08-24Bio Medica Laboratories is a SME IPO with an issue size of ₹52.43 crore, proposed for listing on NSE SME. The offer opens on 21st May 2026 and closes on 25th May 2026. The issue structure includes a fresh issue of ₹44.56 crore and an offer-for-sale component of ₹5.24 crore.
Issue details
Listing atNSE SME
Issue typeBook Build Issue
Issue size₹52.43 Cr
Fresh issue₹44.56 Cr
Offer for sale₹5.24 Cr
Face value₹10
Price band₹132.00–₹139.00
Allotment26th May 2026
Listing29th May 2026
Grey market
GMP page ↗Latest GMPNO GMP
GMP / upper priceNO DATA
Est. listing₹130.00
GMP is unofficial sentiment data, not an exchange price.
Timeline
Opens21st May 2026
Closes25th May 2026
Allotment26th May 2026
Refund27th May 2026
Demat27th May 2026
Listing29th May 2026
Subscription demand
Full bidding ↗Total2.26×
Lot size
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 2000 | ₹278,000 |
Company
Use of proceeds
| Object | Amount |
|---|---|
| Repayment of loan | ₹6.50 Cr |
| Enhancement of its existing production capabilities by setting up of new manufacturing facility at the existing premises | ₹28.50 Cr |
| General Corporate Purposes | ₹7.05 Cr |
| Issue Expense | ₹5.14 Cr |
| Total | ₹47.19 Cr |
Financials
Full financials ↗31 Mar 2024
Assets19.53
Total Income15.34
EBITDA5.63
Profit After Tax2.50
NET Worth4.94
Reserves and Surplus4.84
Total Borrowing10.49
31 Mar 2025
Assets39.12
Total Income38.33
EBITDA15.21
Profit After Tax9.79
NET Worth14.73
Reserves and Surplus5.55
Total Borrowing15.01
30 Nov 2025
Assets65.17
Total Income28.63
EBITDA13.45
Profit After Tax8.66
NET Worth17.12
Reserves and Surplus7.94
Total Borrowing38.17
Trend chart₹ crore
KPIs
| KPI | Mar 31, 2025 | Nov 30, 2025 |
|---|---|---|
| ROE | 99.59% | 54.41% |
| ROCE | 48.20% | 23.22% |
| Debt / Equity | 1.02% | 2.23% |
| RoNW | 99.59% | 54.41% |
| PAT Margin | 25.64% | 30.35% |
| EBITDA Margin | 39.83% | 47.11% |
| Price to Book Value | 8.66 |
Valuation & shareholding
Pre-IPO EPS10.67
Post-IPO EPS10.33
Pre-IPO P/E13.03
Post-IPO P/E13.45
Promoter holding pre96.84%
Promoter holding post67.7%
Market cap₹174.79 Cr.
Issue expenses
| Expense | Amount |
|---|---|
| Book Running Lead manager(s) fees | ₹1.00 Cr |
| Underwriting commission | ₹2.62 Cr |
| Brokerage, selling commission and upload fees | ₹0.02 Cr |
| Registrars to the issue | ₹0.01 Cr |
| Legal Advisors | ₹0.06 Cr |
| Advertising expenses | ₹0.07 Cr |
| Regulators including stock exchanges | ₹0.10 Cr |
| Printing and Distribution of Issue Stationary | ₹0.01 Cr |
| Others, if any (Market Maker fees, Peer Review Auditor, Selling and Distribution Expenses, Marketing Expenses and other misc. expenses) | ₹1.25 Cr |
| Total | ₹5.14 Cr |
Registrar & lead managers
Registrar
Skyline Financial Services Pvt.Ltd.Lead managers
- Location
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-08-24.